Hyper-Progressive Disease on Immunotherapy in Advanced NSCLC (BMIC-012) - 102204

Spotlight
Video

Hyper-Progressive Disease on Immunotherapy in Advanced NSCLC (BMIC-012)

BeaconMedIC has 71 videos Subscribe Here

Loading........
Description: Dr. Jack West reviews evidence that a subset of patients with advanced NSCLC demonstrate "hyper-progressing disease" (HPD), worsening cancer at a faster rate, on immune checkpoint inhibitor therapy, more commonly than seen in patients on chemotherapy.
Shared By : BeaconMedIC
Posted on : 10/27/17
Added : 1 year ago
Category : Immunotherapy